nach oben

Journal of Cancer Survivorship

Erschienen in:

01.09.2012

Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis

verfasst von: J. Michael Underwood, Julie S. Townsend, Eric Tai, Arica White, Shane P. Davis, Temeika L. Fairley

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

People who continue to smoke after a cancer diagnosis have an increased risk for recurrences or development of new malignancies. These risks may be even higher among tobacco-related cancer survivors (TRCS). We describe tobacco use behaviors among TRCS, other cancer survivors, and people without a history of cancer.

Methods

We used 2009 Behavioral Risk Factor Surveillance System data to describe demographic characteristics, smoking history, current smoking prevalence, and smokeless tobacco use among TRCS, other cancer survivors, and people without a history of cancer (cigarette smoking and smokeless tobacco use were calculated after adjusting for age, sex, race, and insurance status). Tobacco-related cancers were defined as lung/bronchial, pharyngeal, laryngeal, esophageal, stomach, pancreatic, kidney/renal, urinary bladder, cervical, and acute myeloid leukemia.

Results

A total of 20 % of all cancer survivors were TRCS. TRCS were primarily female (68 %) and white (78 %). Smoking prevalence was higher among TRCS (27 %) compared with other cancer survivors (16 %) and respondents without a history of cancer (18 %). Smokeless tobacco use was higher among respondents without a history of cancer (4 %) compared with TRCS (3 %) and other cancer survivors (3 %).

Conclusions

The self-reported smoking prevalence among TRCS is higher than among other cancer survivors and people without a history of cancer. Targeted smoking prevention and cessation interventions are needed for cancer survivors, especially those diagnosed with a tobacco-related cancer.

Implications for cancer survivors

We recommend all cancer survivors be made aware of the health risks associated with smoking after a cancer diagnosis, and smoking cessation services be offered to those who currently smoke.

Condensed abstract

We provide the first population-based report on demographic characteristics and tobacco use behaviors among self-reported tobacco-related cancer survivors.

Centers for Disease Control and Prevention. [Cancer Survivors—United States, 2007]. MMWR Morb Mortal Wkly Rep 2011;60:269–272.

Fairley TL, Pollack LA, Moore AR, Smith JL. Addressing cancer survivorship through public health: an update from the Centers for Disease Control and Prevention. J Womens Health (Larchmt). 2009;18(10):1525–31.CrossRef

Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.PubMedCrossRef

Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117.PubMedCrossRef

Pollack LA, Rowland JH, Crammer C, Stefanek M. Introduction: charting the landscape of cancer survivors' health-related outcomes and care. Cancer. 2009;115(18 Suppl):4265–9.PubMedCrossRef

Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship: Improving Care and Quality of Life. Washington: National Academies Press; 2006.

Centers for Disease Control and Prevention: annual smoking attributable mortality, years of potential life lost, and economic costs. United States 1995–1999. MMWR Morb Mortal Wkly Rep. 2004;Centers for Disease Control and Prevention.

The 2004 United States Surgeon General's Report: the health consequences of smoking. NSW Public Health Bull. 2004;15(5–6):107.

Stewart SL, Cardinez CJ, Richardson LC, et al. Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR Surveill Summ. 2008;57(8):1–33.PubMed

10.

Klosky JL, Tyc VL, Garces-Webb DM, Buscemi J, Klesges RC, Hudson MM. Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. Cancer. 2007;110(11):2408–19.PubMedCrossRef

11.

Mackenbach JP, Borsboom GJ, Nusselder WJ, Looman CW, Schrijvers CT. Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study. J Epidemiol Community Health. 2001;55(9):631–8.PubMedCrossRef

12.

Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119(5):383–90.PubMed

13.

Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608–16.PubMedCrossRef

14.

Mulhern RK, Tyc VL, Phipps S, Crom D, Barclay D, Greenwald C, et al. Health-related behaviors of survivors of childhood cancer. Med Pediatr Oncol. 1995;25(3):159–65.PubMedCrossRef

15.

Tyc VL, Klosky JL, Lensing S, Throckmorton-Belzer L, Rai SN. A comparison of tobacco-related risk factors between preadolescents with and without cancer. J Cancer Surviv. 2009;3(4):251–9.PubMedCrossRef

16.

Emmons KM, Butterfield RM, Puleo E, Park ER, Mertens A, Gritz ER, et al. Smoking among participants in the childhood cancer survivors cohort: the partnership for health study. J Clin Oncol. 2003;21(2):189–96.PubMedCrossRef

17.

Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632–44.PubMedCrossRef

18.

Fairley TL, Hawk H, Pierre S. Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: data use for comprehensive cancer control. Prev Chronic Dis. 2010;7(1):A09.PubMedCrossRef

19.

Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck Jr BE, Ihde DC, et al. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980;244(19):2175–9.PubMedCrossRef

20.

Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733–41.PubMedCrossRef

21.

Tao ML, Guo MD, Weiss R, Byrne J, Mills JL, Robison LL, et al. Smoking in adult survivors of childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 1998;90(3):219–25.PubMedCrossRef

22.

Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. lancet Oncol. 2008;9(7):667–75.PubMedCrossRef

23.

Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med. 2004;15(5):252.PubMedCrossRef

24.

Rodu B, Cole P. Smokeless tobacco use and cancer of the upper respiratory tract* 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(5):511–5.PubMedCrossRef

25.

Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer. 2005;114(6):992–5.PubMedCrossRef

26.

Tyc VL, Hadley W, Crockett G. Prediction of health behaviors in pediatric cancer survivors. Med Pediatr Oncol. 2001;37(1):42–6.PubMedCrossRef

27.

Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer. JAMA J Am Med Assoc. 2008;300(23):2765.CrossRef

28.

Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2.PubMedCrossRef

29.

Centers for Disease Control and Prevention. Public health surveillance for behavioral risk factors in a changing environment: recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Morb Mortal Wkly Rep. 2003;52:1–12.

30.

Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, et al. The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med. 1985;1(6):9–14.PubMed

31.

Behavioral Risk Factor Surveillance System: 2009 Summary Data Quality Report [Internet].

32.

Behavioral Risk Factor Surveillance System: 2009 Summary Data Quality Report [Internet]. Atlanta, GA: Centers for Disease Control and Prevention, 2010. Available at: ftp://ftp.cdc.gov/pub/Data/Brfss/2009_Summary_Data_Quality_Report.pdf. Accessed 19 Jul 2010

33.

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.PubMedCrossRef

34.

Centers for Disease Control and Prevention. Current trends smoking prevalence and cessation in selected States, 1981–1983 and 1985—The Behavioral Risk Factor Surveys. MMWR Morb Mortal Wkly Rep. 1986;35(47):740–3.

35.

Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566–71.PubMedCrossRef

36.

Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63.PubMedCrossRef

37.

Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2287–93.PubMedCrossRef

38.

Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, et al. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005;47(2):165–72.PubMedCrossRef

39.

Centers for Disease Control and Prevention (CDC), Vital Signs. Smoking and Tobacco Use. Atlanta, GA. Available at: http://www.cdc.gov/tobacco/data_statistics/vital_signs/index.htm. Accessed August, 29 2011.

40.

Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23(34):8884–93.PubMedCrossRef

41.

Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >/=18 years—United States, 2005–2010. MMWR Morb Mortal Wkly Rep. 2011;60(35):1207–12.

42.

Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health. 2002;92(6):1002–6.PubMedCrossRef

43.

National Institutes of Health (NIH), NCI,. Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Cervix Uteri. Bethesda: NCI, 2011. Accessed at: http://www.seer.cancer.gov/statfacts/html/cervix.html. Accessed 30 May 2011.

44.

Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20–8.PubMedCrossRef

45.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.PubMedCrossRef

46.

Coker AL, DeSimone CP, Eggleston KS, Hopenhayn C, Nee J, Tucker T. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005. Gynecol Oncol. 2009;112(2):365–9.PubMedCrossRef

47.

Flint AJ, Novotny TE. Poverty status and cigarette smoking prevalence and cessation in the United States, 1983–1993: the independent risk of being poor. Tob Control. 1997;6(1):14–8.PubMedCrossRef

48.

Zhu BP, Giovino GA, Mowery PD, Eriksen MP. The relationship between cigarette smoking and education revisited: implications for categorizing persons' educational status. Am J Public Health. 1996;86(11):1582–9.PubMedCrossRef

49.

Doescher MP, Jackson JE, Jerant A, Gary Hart L. Prevalence and trends in smoking: a national rural study. J Rural Health. 2006;22(2):112–8.PubMedCrossRef

50.

Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687–91.PubMedCrossRef

51.

Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer. 2004;101(5):1051–7.PubMedCrossRef

52.

Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstet Gynecol. 2007;110(3):681–6.PubMedCrossRef

53.

Fiore M. Treating tobacco use and dependence: 2008 update: clinical practice guideline. Darby: DIANE Publishing; 2008.

54.

Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment. Cancer. 2006;106(1):17–27.PubMedCrossRef

55.

Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009;24 Suppl 2:S480–6.PubMedCrossRef

56.

57.

Nathan PC, Ford JS, Henderson TO, Hudson MM, Emmons KM, Casillas JN, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2363.PubMedCrossRef

58.

Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, et al. Methods used to quit smoking in the United States. JAMA J Am Med Assoc. 1990;263(20):2760.CrossRef

59.

International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, smoking and tobacco use: volume 89. Smokeless tobacco and some tobacco-specific N-nitrosamines, Lyon, France 2007. Available at: http://monographs.iarc.fr/ENG/Monographs/vol89/mono89.pdf. Accessed 31 October 2011.

60.

Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299–306.PubMedCrossRef

61.

Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999;91(17):1480–6.PubMedCrossRef

62.

Blumberg SJ, Luke JV. Wireless substitution: early release of estimates from the National Health Interview Survey, July–December 2007. 2008.

63.

Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003;93(8):1335–41.PubMedCrossRef

64.

Emmons KM, Puleo E, Park E, Gritz ER, Butterfield RM, Weeks JC, et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol. 2005;23(27):6516.PubMedCrossRef

65.

Graubard BI, Korn EL. Predictive margins with survey data. Biom. 1999;55(2):652–9.

66.

Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. J Clin Oncol. 2002;20(6):1608–16.PubMedCrossRef

67.

Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. J Clin Oncol. 2005;23(24):5814–30.PubMedCrossRef

68.

Centers for Disease Control and Prevention, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Morb Mortal Wkly Rep. 2012;61(1):1–23.

69.

Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer [Research Support, U.S. Gov't, P.H.S.]. Cancer Causes Control. 1991;2(2):105–12.PubMedCrossRef

70.

Underwood JM, Rim SH, Fairley TL, Tai E, Stewart SL. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008. Cancer Causes Control. 2012;(in press)

71.

Mayer DK, Carlson J. Smoking patterns in cancer survivors. Nicotine Tob Res. 2011;13(1):34–40.PubMedCrossRef

Titel: Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis
verfasst von: J. Michael Underwood
Julie S. Townsend
Eric Tai
Arica White
Shane P. Davis
Temeika L. Fairley
Publikationsdatum: 01.09.2012
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 3/2012
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-012-0230-1

Springer Medizin

Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis

Abstract

Introduction

Methods

Results

Conclusions

Implications for cancer survivors

Condensed abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusions

Implications for cancer survivors

Condensed abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors

A cohort study of permanently reduced work ability in breast cancer patients

Fostering partnerships in survivorship care: report of the 2011 Canadian genitourinary cancers survivorship conference

Cancer perceptions: implications from the 2007 Health Information National Trends Survey

Disease self-management needs of adolescents with cancer: perspectives of adolescents with cancer and their parents and healthcare providers

Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie